At a glance
ClinicalIndex Comparison RecordN/ACompleted· 17 enrolled
Drug / intervention
Insulin (circadian) +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Study of Flat and Circadian Insulin Infusion Rates in Continuous Subcutaneous Insulin Infusion (CSII) in Adults With Type 1 Diabetes
In Brief
A clinical study evaluating Insulin (circadian) and Insulin (flat rate) for Type 1 Diabetes. Completed, enrolled 17 participants across 1 site.
Detailed Summary
Randomised controlled trial to contribute to the evidence base for the optimal initial insulin profile for adults with type 1 diabetes commencing insulin pump therapy.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 1 Diabetes
CountriesUnited Kingdom
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
Enrollment StartApr 2018
Primary CompletionNov 2018
First PostedFeb 2020
TodayJul 2026
First PostedFeb 13, 2020
Enrollment StartApr 10, 2018
Primary CompletionNov 9, 2018
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 6.4 years ago
Interventions
Insulin (circadian)drug
Participant's own insulin adjusted to circadian infusion rates
Insulin (flat rate)drug
Participant's own insulin set to flat basal rates